1. Pollyea DA, Brown JMY, Horning SJ. Utility of influenza vaccination for oncology patients. J Clin Oncol.2010;28(14):2481-90.
2. Beck CR, McKenzie BC, Hashim AB,Harris RC, Nguyen-Van-Tam JS. Influenza vaccination for immunocompromised patients: Systematic review and meta-analysis by etiology. J Infect Dis.2012;206(8):1250-9.
3. Kuo AM, Brown JN, Clinard V. Effect of influenza vaccination on international normalized ratio during chronic warfarin therapy. J Clin PharmTher. 2012;37(5):505-9
4. Australasian Society of Clinical Immunology and Allergy. Vaccination of the egg-allergic individual [Internet].Sydney: Australasian Society of Clinical Immunology and Allergy; 2017 [Available from: https://www.allergy.org.au/hp/papers/vaccination-of-the-egg-allergic-individual https://www.allergy.org.au/hp/papers/vaccination-of-the-egg-allergic-individual
5. Medsafe. Data sheet – Fluad Quad [Internet]. Wellington: New Zealand Medicines and Medical Devices Safety Authority; 2020 [updated 2020December 11; cited 2021 February 3]. Available from:https://www.medsafe.govt.nz/profs/datasheet/f/FluadQuadinj.pdf
6. Medsafe. Data sheet – Afluria Quad/Afluria Quad Junior[Internet]. Wellington: New Zealand Medicines and Medical Devices Safety Authority; 2017 [updated 2021 March 12; cited 2021 March 30]. Available from:https://www.medsafe.govt.nz/profs/ Datasheet/a/Afluriainj.pdf https://www.medsafe.govt.nz/profs/datasheet/a/Afluriainj.pdf
7. Medsafe. Data sheet – Flu Quadri[Internet] Wellington: New Zealand Medicines and Medical Devices Safety Authority; 2022 [updated 2022 January 26; cited 2022 Feb
ruary 15]. Available from: https://www.medsafe.govt.nz/profs/datasheet/f/ fluquadriinj.pdf
8. Australasian Society of Clinical Immunology and Allergy. Sulfonamide antibiotic allergy [Internet]. Sydney: Australasian Society of Clinical Immunology and Allergy Inc; 2019 [Available from:https://www.allergy.org.au/images/pcc/ASCIA_PCC_Sulfonamide_antibiotic_allergy_2016.pdf
